Literature DB >> 26022259

Nitric Oxide-GAPDH Transcriptional Signaling Mediates Behavioral Actions of Cocaine.

Maged M Harraz, Solomon H Snyder1.   

Abstract

Psychotropic actions of cocaine are generally thought to involve its blockade of monoamine transporters leading to increased synaptic levels of monoamines, especially dopamine. Subsequent intracellular events have been less well characterized. We describe a signaling system wherein lower behavioral stimulant doses of cocaine, as well as higher neurotoxic doses, activate a cascade wherein nitric oxide nitrosylates glyceraldehyde-3-phosphate dehydrogenase (GAPDH) to generate a complex with the ubiquitin-E3-ligase Siah1 which translocates to the nucleus. With lower cocaine doses, nuclear GAPDH augments CREB signaling, while at higher doses p53 signaling is enhanced. The drug CGP3466B very potently blocks GAPDH nitrosylation, hindering both signaling cascades and inhibits both behavioral activating and neurotoxic effects of cocaine. This system affords potentially novel approaches to the therapy of cocaine abuse.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26022259      PMCID: PMC4831565          DOI: 10.2174/1871527314666150529150143

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  53 in total

1.  Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices.

Authors:  R E Heikkila; H Orlansky; G Cohen
Journal:  Biochem Pharmacol       Date:  1975-04-15       Impact factor: 5.858

2.  The neuroprotective effects of CGP 3466B in the best in vivo model of Parkinson's disease, the bilaterally MPTP-treated rhesus monkey.

Authors:  G Andringa; A R Cools
Journal:  J Neural Transm Suppl       Date:  2000

3.  Neurorescuing effects of the GAPDH ligand CGP 3466B.

Authors:  P C Waldmeier; A A Boulton; A R Cools; A C Kato; W G Tatton
Journal:  J Neural Transm Suppl       Date:  2000

Review 4.  Noradrenaline: fate and control of its biosynthesis.

Authors:  J Axelrod
Journal:  Science       Date:  1971-08-13       Impact factor: 47.728

5.  Diethyldithiocarbamate and amphetamine stereotype behavior.

Authors:  A Randrup; J Scheel-Krüger
Journal:  J Pharm Pharmacol       Date:  1966-11       Impact factor: 3.765

6.  Uptake of some tritiated sympathomimetic amines by mouse brain cortex slices in vitro.

Authors:  S B Ross; A L Renyi
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1966

7.  [Uptake of 5-hydroxytryptamine and 5-hydroxytrytophan in normally catecholamine-containing neurons of the central nervous system].

Authors:  W Lichtensteiger; U Mutzner; H Langemann
Journal:  Helv Physiol Pharmacol Acta       Date:  1966-11

8.  Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats.

Authors:  P H Kelly; S D Iversen
Journal:  Eur J Pharmacol       Date:  1976-11       Impact factor: 4.432

9.  CGP 3466 protects dopaminergic neurons in lesion models of Parkinson's disease.

Authors:  P C Waldmeier; W P Spooren; B Hengerer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2000-12       Impact factor: 3.000

10.  An orally active anti-apoptotic molecule (CGP 3466B) preserves mitochondria and enhances survival in an animal model of motoneuron disease.

Authors:  Y Sagot; N Toni; D Perrelet; S Lurot; B King; H Rixner; L Mattenberger; P C Waldmeier; A C Kato
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

View more
  2 in total

1.  ASL Metabolically Regulates Tyrosine Hydroxylase in the Nucleus Locus Coeruleus.

Authors:  Shaul Lerner; Elmira Anderzhanova; Sima Verbitsky; Raya Eilam; Yael Kuperman; Michael Tsoory; Yuri Kuznetsov; Alexander Brandis; Tevie Mehlman; Ram Mazkereth; Robert McCarter; Menahem Segal; Sandesh C S Nagamani; Alon Chen; Ayelet Erez
Journal:  Cell Rep       Date:  2019-11-19       Impact factor: 9.423

2.  ASL expression in ALDH1A1+ neurons in the substantia nigra metabolically contributes to neurodegenerative phenotype.

Authors:  Shaul Lerner; Raya Eilam; Lital Adler; Julien Baruteau; Topaz Kreiser; Michael Tsoory; Alexander Brandis; Tevie Mehlman; Mina Ryten; Juan A Botia; Sonia Garcia Ruiz; Alejandro Cisterna Garcia; Carlo Dionisi-Vici; Giusy Ranucci; Marco Spada; Ram Mazkereth; Robert McCarter; Rima Izem; Thomas J Balmat; Rachel Richesson; Ehud Gazit; Sandesh C S Nagamani; Ayelet Erez
Journal:  Hum Genet       Date:  2021-08-21       Impact factor: 4.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.